Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from TG Therapeutics

Briumvi's Strong Sales Can't Stop TG Therapeutics Stock Slide

TG Therapeutics Inc. (NASDAQ:TGTX) stock is trading lower on Monday after the company reported worse-than-expected second-quarter 2025 earnings.

Benzinga

Why Top 3% Stock TG Therapeutics Crashed Despite Raising Its 2025 Outlook

TG Therapeutics stock crashed Monday after the drugmaker reported in-line sales of Briumvi, but missed second-quarter profit expectations.

Investors Business Daily

Analysts Hike Profit Targets On This Gold Stock, Defense Name

A gold stock and a defense technology name both soared around 70% so far this year. And analysts see 471% profit growth on a biotech name.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

TG Therapeutics Joins Elite List Of Stocks With 95-Plus Composite Rating

TG Therapeutics saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 93 to 97.

Investors Business Daily

TG Therapeutics Joins Rank Of Stocks With RS Ratings Over 90

A Relative Strength Rating upgrade for TG Therapeutics shows improving technical performance.

Investors Business Daily

TG Therapeutics Sees Its Composite Rating Rise To 96

On Monday, TG Therapeutics got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96.

Investors Business Daily

Stocks With Rising Composite Ratings: TG Therapeutics

TG Therapeutics saw an improvement in its IBD SmartSelect Composite Rating Wednesday, from 94 to 96.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Trump Tariffs Trigger Bear Market. Investor Focus Shifts Here.

A bear market takes hold as Trump tariffs hammer stocks. With IBD Leaderboard trimmed to just seven names, safety and preparation are in focus.

Investors Business Daily

IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche

TG Therapeutics rallied Wednesday after Roche's rival multiple sclerosis treatment, Ocrevus, missed its mark in a study.

Investors Business Daily

Biotech Stock TG Therapeutics Hits A High In Market Meltdown

Biotech stock TG Therapeutics is outperforming the major indexes in a declining stock market. TGTX stock hit a new high on Friday.

Investors Business Daily

This Biotech Stock Hits Buy Point After Earnings Burst

TGTX stock is climbing and broke out of a base Thursday. TG Therapeutics reported a robust earnings report on Monday.

Investors Business Daily

Meta, Netflix Hold Tough As Tech Tanks. This Biotech Booms.

While Netflix and Meta stock fight to shake off market volatility, Eli Lilly and this biotech stock join them and others on IBD Leaderboard.

Investors Business Daily

TG Therapeutics, A New Leaderboard Stock, Skyrockets 14% On Sales Beat, Bullish Guide

TG Therapeutics stock skyrocketed Monday after easily beating fourth-quarter sales expectations and issuing a bullish outlook for 2025.

Investors Business Daily

TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

TG Therapeutics (NASDAQ:TGTX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review

The stock market surged to highs on Donald Trump's election win. A Fed rate cut and a slew of big earnings reports filled out a busy week.

Investors Business Daily

TG Therapeutics Crashes — Reversing A Breakout — After Missing 'Whisper' Expectations

TG Therapeutics stock crashed Monday after missing profit expectations, though sales of its multiple sclerosis treatment beat forecasts.

Investors Business Daily

AI Stocks Meta, Oracle Lead Five Names Near Buy Points

Two of the five top stocks to watch this week target the artificial intelligence market.

Investors Business Daily

As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report

Amid the election, and a Fed rate vote, earnings season roars ahead.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage)

The Dow, S&P 500 and Nasdaq closed 0.3% lower.

Investors Business Daily

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi.

Investors Business Daily

IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter

TG Therapeutics stock broke out Monday less than two weeks after the biotech company reported a surprise profit for the June quarter.

Investors Business Daily

IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability

TG Therapeutics stock is the IBD Stock Of The Day as shares approach two potential entries on newfound profitability and booming sales.

Investors Business Daily

Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review

Monday's global sell-off turned into a stock market rally attempt. Palantir, Eli Lilly and Fortinet were among the earnings winners.

Investors Business Daily

TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157%

TG Therapeutics stock popped Tuesday after the drugmaker unexpectedly reported a second-quarter profit, thanks to significantly lower R&D.

Investors Business Daily

Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area

Among the best stocks to watch, biotech leader TG Therapeutics is clearing a key resistance area on the stock market today.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations